Srini Ramanathan
Corporate Officer/Principal bij ROIVANT SCIENCES LTD.
Actieve functies van Srini Ramanathan
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ROIVANT SCIENCES LTD. | Corporate Officer/Principal | 02-05-2022 | - |
Loopbaan van Srini Ramanathan
Eerdere bekende functies van Srini Ramanathan
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - | - |
Opleiding van Srini Ramanathan
| Duquesne University School of Law | Graduate Degree |
| Rutgers State University of New Jersey | Doctorate Degree |
Statistieken
Internationaal
| Verenigd Koninkrijk | 2 |
| Ierland | 2 |
| Verenigde Staten | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ROIVANT SCIENCES LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Beurs
- Insiders
- Srini Ramanathan
- Ervaring
